Mike Pearson tells listeners how sorghum eyes the premium market as Ancient Grain Health Study launches.
The sorghum industry is positioning itself to capitalize on the growing ancient grains market through groundbreaking health research that could unlock premium pricing opportunities for producers.
The United Sorghum Checkoff Program has launched the first human clinical trial examining whole grain sorghum's health benefits, conducted by the University of Nebraska at Lincoln with USDA co-funding. This randomized crossover study focuses on adults with obesity, testing two distinct sorghum varieties daily: traditional white sorghum and a phenolic-rich variety called sumac sorghum.
Key Health Metrics Being Measured:
- Insulin resistance levels
- Inflammation markers
- Gut microbiome composition changes
- Body weight fluctuations
- Blood pressure variations
- Lipid profile improvements
The implications for sorghum producers could be transformative. If results prove positive, the checkoff program plans to pursue qualified health claims with the FDA and partner with food manufacturers to develop sorghum-based products carrying official health credentials.
This research represents a strategic shift for the sorghum industry, which has traditionally emphasized drought tolerance and crop rotation benefits. Now, grain quality, nutritional value, and functional ingredient branding are becoming equally important considerations for producers seeking market differentiation.
The timing appears opportune, as the ancient grains market continues rapid expansion. Between 2021 and 2024, over 1,200 new products containing ancient grains entered the market, with North America leading global growth in this sector. Consumers have consistently demonstrated willingness to pay premiums for ancient grain products, creating potential opportunities for sorghum growers.
However, industry experts caution that this development remains in early stages. The clinical trial is just beginning, and results have not yet been published. Success will depend on demonstrating measurable health benefits that can translate into FDA-approved health claims and consumer demand for sorghum-based products.